Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of ARS Pharmaceuticals Inc (NASDAQ: SPRY) was $12.33 for the day, down -3.90% from the previous closing price of $12.83. In other words, the price has decreased by -$3.90 from its previous closing price. On the day, 1.49 million shares were traded. SPRY stock price reached its highest trading level at $13.42 during the session, while it also had its lowest trading level at $12.03.
Ratios:
Our analysis of SPRY’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 93.21. For the most recent quarter (mrq), Quick Ratio is recorded 14.04 and its Current Ratio is at 14.26. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $30.
On February 10, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $40.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 07 ’25 when Shawver Laura sold 50,002 shares for $12.30 per share. The transaction valued at 615,075 led to the insider holds 210,346 shares of the business.
Shawver Laura bought 50,002 shares of SPRY for $615,051 on Apr 07 ’25. On Mar 20 ’25, another insider, Karas Eric, who serves as the Chief Commercial Officer of the company, sold 10,000 shares for $14.00 each. As a result, the insider received 140,000 and left with 7,696 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1209817088 and an Enterprise Value of 1011336512. As of this moment, ARS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 160.76. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.57 while its Price-to-Book (P/B) ratio in mrq is 4.70. Its current Enterprise Value per Revenue stands at 11.344 whereas that against EBITDA is -336.663.
Stock Price History:
The Beta on a monthly basis for SPRY is 0.75, which has changed by 0.33009708 over the last 52 weeks, in comparison to a change of -0.034466684 over the same period for the S&P500. Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $7.55. The 50-Day Moving Average of the stock is 2.24%, while the 200-Day Moving Average is calculated to be -1.56%.
Shares Statistics:
SPRY traded an average of 1.65M shares per day over the past three months and 1987450 shares per day over the past ten days. A total of 97.95M shares are outstanding, with a floating share count of 56.04M. Insiders hold about 42.88% of the company’s shares, while institutions hold 50.12% stake in the company. Shares short for SPRY as of 1741910400 were 19429266 with a Short Ratio of 11.81, compared to 1739491200 on 16483868. Therefore, it implies a Short% of Shares Outstanding of 19429266 and a Short% of Float of 37.04.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
